But the mechanistic differences explain why researchers are increasingly interested in their potential for mood disorders, particularly for individuals who have not responded to conventional treatments
Food and Drug Administration (FDA) has approved semaglutide (marketed as Wegovy) and Tirzepatide (marketed as Zepbound) specifically for chronic weight management in adults with obesity or overweight individuals with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
Isik S, Ozcan HN, Ozuguz U, Berker D, Tutuncu Y, Akbaba G, Guler S
(PubMed) Zeng T, Zhang CL, Zhao XL, Xie KQ
Studies have demonstrated that TCM treatment increases the abundance of beneficial bacteria while inhibiting pathogenic bacterias proliferation
Can I Have a B12 Deficiency If My Blood Test Was Normal